Glycosaminoglycans and activated contact system in cancer patient plasmas

Progress in Molecular Biology and Translational Science

Volumn 93, Issue C, 2010, Pages 473-495

  Pan, Jing ^a   Qian, Yi ^a   Weiser, Peter ^a   Zhou, Xiaodong ^a   Lu, Hong ^a   Studelska, Daniel R ^a   Zhang, Lijuan ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

C1 inhibitor; Cancer; Factor XII; Glycosaminoglycan; Kallikrein; Kininogen; TAFI; Thrombin

Indexed keywords

AUTOANTIGEN; GLYCOSAMINOGLYCAN; THROMBIN;

ANIMAL; HUMAN; IMMUNOLOGY; METABOLISM; NEOPLASM; PATHOLOGY; REVIEW;

ANIMALS; AUTOANTIGENS; GLYCOSAMINOGLYCANS; HUMANS; NEOPLASMS; THROMBIN;

EID: 77958176290     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1877-1173(10)93020-2     Document Type: Chapter

References (54)

1. M.J. Thun, L.M. Hannan, L.L. Adams-Campbell, P. Boffetta, J.E. Buring, and D. Feskanich Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies PLoS Med 5 2008 e185
2. S.A. Mousa Role of current and emerging antithrombotics in thrombosis and cancer Timely Top Med Cardiovasc Dis 10 2006 E19
3. I.M. Sainz, R.A. Pixley, and R.W. Colman Fifty years of research on the plasma kallikreinkinin system: from protein structure and function to cell biology and in vivo pathophysiology Thromb Haemost 98 2007 77 83
4. A. Varki Trousseau's syndrome: multiple definitions and multiple mechanisms Blood 110 2007 1723 1729
5. C. de la Fouchardiere, A. Flechon, and J.P. Droz Coagulopathy in prostate cancer Neth J Med 61 2003 347 354
6. G.H. Sack Jr, J. Levin, and W.R. Bell Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features Medicine (Baltimore) 56 1977 1 37
7. N.S. Jenny, R.L. Lundblad, and K.G. Mann Thrombin R.W. Colman, Hemostasis and thrombosis 2006 Lippincott Williams & Wilkins Philadelphia 193 213
8. E.S. Mullins, K.W. Kombrinck, K.E. Talmage, M.A. Shaw, D.P. Witte, and J.M. Ullman Genetic elimination of prothrombin in adult mice is not compatible with survival and results in spontaneous hemorrhagic events in both heart and brain Blood 113 2009 696 704
9. M.L. Nierodzik, and S. Karpatkin Thrombin induces tumor growth, metastasis, and angiogenesis: evidence for a thrombin-regulated dormant tumor phenotype Cancer Cell 10 2006 355 362
10. J. Folkman Antiangiogenesis in cancer therapyendostatin and its mechanisms of action Exp Cell Res 312 2006 594 607
11. S.R. Coughlin Protease-activated receptors in hemostasis, thrombosis and vascular biology J Thromb Haemost 3 2005 1800 1814
12. Y. Qian, J. Pan, X. Zhou, P. Weiser, H. Lu, and F.F. Shih Heparin and oversulfated heparin byproduct induce thrombin generation through contact system activation in plasma of patients with HIT Clin Appl Thromb Hemost 16 2010 251 260
13. E. Di Cera Thrombin Mol Aspects Med 29 2008 203 254
14. M. Huber-Lang, J.V. Sarma, F.S. Zetoune, D. Rittirsch, T.A. Neff, and S.R. McGuire Generation of C5a in the absence of C3: a new complement activation pathway Nat Med 12 2006 682 687
15. T. Orfeo, K.E. Brummel-Ziedins, M. Gissel, S. Butenas, and K.G. Mann The nature of the stable blood clot procoagulant activities J Biol Chem 283 2008 9776 9786
16. Y. Qian, J. Pan, X. Zhou, P. Weiser, D. Hourcade, and K.M. Lizsewski Oversulfated heparin byproducts induce thrombin generation through contact system activation Clin Appl Thromb Hemost 16 2010 244 250
17. T.W. Stief Kallikrein activates prothrombin Clin Appl Thromb Hemost 14 2008 97 98
18. R.W. Colman, A.W. Clowes, J.N. George, S.Z. Goldhaber, and V.J. Marder Overview of hemostasis R.W. Colman, Hemostasis and thrombosis 2006 Lippincott Williams & Wilkins Philadelphia 3 16
19. A.Y. Lee Cancer and thromboembolic disease: pathogenic mechanisms Cancer Treat Rev 28 2002 137 140
20. B. Furie, and B.C. Furie Mechanisms of thrombus formation N Engl J Med 359 2008 938 949
21. F. Schaffner, and W. Ruf Tissue factor and protease-activated receptor signaling in cancer Semin Thromb Hemost 34 2008 147 153
22. R.W. Colman Contact activation (kallikrein-kinin) pathway: multiple physiologic and pathophysiologic activities R.W. Colman, Hemostasis and thrombosis 2006 Lippincott Williams & Wilkins Philadelphia 107 130
23. B.A. Waaler Contact activation in the intrinsic blood clotting system; studies on a plasma product formed on contact with glass and similar surfaces Scand J Clin Lab Invest 11 1959 1 133
24. T.K. Kishimoto, K. Viswanathan, T. Ganguly, S. Elankumaran, S. Smith, and K. Pelzer Contaminated heparin associated with adverse clinical events and activation of the contact system N Engl J Med 358 2008 2457 2467 (Pubitemid 351793019)
25. J. Pan, Y. Qian, X. Zhou, A. Pazandak, S.B. Frazier, and P. Weiser Oversulfated chondroitin sulfate is not the sole contaminant in heparin Nat Biotechnol 28 2010 203 207
26. J. Pan, Y. Qian, X. Zhou, A. Pazandak, S.B. Frazier, and P. Weiser Identification of chemically sulfated/desulfated glycosaminoglycans in contaminated heparins and development of a simple assay for the detection of most contaminants in heparin Glycobiology Insights 2 2010 1 12
27. J. Pan, Y. Qi, X. Zhou, H. Lu, E. Ramacciotti, and L. Zhang Chemically oversulfated glycosaminoglycans are potent modulators of contact system activation and different cell signaling pathways J Biol Chem 2010 10.1074/jbc.M109.063735
28. D.R. Studelska, K. Giljum, L.M. McDowell, and L. Zhang Quantification of glycosaminoglycans by reversed-phase HPLC separation of fluorescent isoindole derivatives Glycobiology 16 2006 65 72
29. B.L. Zuraw, and J.G. Curd Demonstration of modified inactive first component of complement (C1) inhibitor in the plasmas of C1 inhibitor-deficient patients J Clin Invest 78 1986 567 575
30. C. Seidel, A. Sundan, M. Hjorth, I. Turesson, I.M. Dahl, and N. Abildgaard Serum syndecan-1: a new independent prognostic marker in multiple myeloma Blood 95 2000 388 392
31. J. Filmus, and M. Capurro Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma Mol Diagn 8 2004 207 212
32. S. Sarrazin, E. Adam, M. Lyon, F. Depontieu, V. Motte, and C. Landolfi Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy Biochim Biophys Acta 1765 2006 25 37
33. I. Osman, D.F. Bajorin, T.-T. Sun, H. Zhong, D. Douglas, and J. Scattergood Novel blood biomarkers of human urinary bladder cancer Clin Cancer Res 12 2006 3374 3380
34. M.R. Campoli, C.C. Chang, T. Kageshita, X. Wang, J.B. McCarthy, and S. Ferrone Human high molecular weight-melanoma-associated antigen (HMW-MAA): a melanoma cell surface chondroitin sulfate proteoglycan (MSCP) with biological and clinical significance Crit Rev Immunol 24 2004 267 296
35. I.J. Vergilis, M. Szarek, S. Ferrone, and S.R. Reynolds Presence and prognostic significance of melanoma-associated antigens CYT-MAA and HMW-MAA in serum of patients with melanoma J Invest Dermatol 125 2005 526 531
36. S.S. Skandalis, D. Kletsas, D. Kyriakopoulou, M. Stavropoulos, and D.A. Theocharis The greatly increased amounts of accumulated versican and decorin with specific post-translational modifications may be closely associated with the malignant phenotype of pancreatic cancer Biochim Biophys Acta 1760 2006 1217 1225
37. T. Horai, N. Nakamura, R. Tateishi, and S. Hattori Glycosaminoglycans in human lung cancer Cancer 48 1981 2016 2021
38. B.D. Grigoriu, F. Depontieu, A. Scherpereel, D. Gourcerol, P. Devos, and T. Ouatas Endocan expression and relationship with survival in human non-small cell lung cancer Clin Cancer Res 12 2006 4575 4582
39. M.R. Abid, X. Yi, K. Yano, S.-C. Shih, and W.C. Aird Vascular endocan is preferentially expressed in tumor endothelium Microvasc Res 72 2006 136 145
40. M.J. Duffy CA 19-9 as a marker for gastrointestinal cancers: a review Ann Clin Biochem 35 Pt 3 1998 364 370
41. B.W. Yin, A. Dnistrian, and K.O. Lloyd Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene Int J Cancer 98 2002 737 740
42. G.F. Pineo, M.C. Brain, A.S. Gallus, J. Hirsh, M.W. Hatton, and E. Regoeczi Tumors, mucus production, and hypercoagulability Ann NY Acad Sci 230 1974 262 270
43. B.A. Biggee, C.M. Blinn, T.E. McAlindon, M. Nuite, and J.E. Silbert Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness Ann Rheum Dis 65 2006 222 226
44. M.G. Wahrenbrock, and A. Varki Multiple hepatic receptors cooperate to eliminate secretory mucins aberrantly entering the bloodstream: are circulating cancer mucins the "tip of the iceberg"? Cancer Res 66 2006 2433 2441
45. E.N. Harris, J.A. Weigel, and P.H. Weigel The human hyaluronan receptor for endocytosis (HARE/Stabilin-2) is a systemic clearance receptor for heparin J Biol Chem 283 2008 17341 17350
46. E.N. Harris, S.V. Kyosseva, J.A. Weigel, and P.H. Weigel Expression, processing, and glycosaminoglycan binding activity of the recombinant human 315-kDa hyaluronic acid receptor for endocytosis (HARE) J Biol Chem 282 2007 2785 2797
47. F.E. Stanley, A.M. Warner, S.M. Gutierrez, and A.M. Stalcup Heparin-induced circular dichroism of chloroquine Biochem Biophys Res Commun 388 2009 28 30
48. B.A. Binstadt, P.R. Patel, H. Alencar, P.A. Nigrovic, D.M. Lee, and U. Mahmood Particularities of the vasculature can promote the organ specificity of autoimmune attack Nat Immunol 7 2006 284 292
49. W.L. Duvall Antithrombotic therapy Curr Mol Med 6 2006 603 619
50. M. Bartnik, A. Norhammar, and L. Ryden Hyperglycaemia and cardiovascular disease J Int Med 262 2007 145 156
51. A. Grand'Maison, A.F. Charest, and W.H. Geerts Anticoagulant use in patients with chronic renal impairment Am J Cardiovasc Drugs 5 2005 291 305
52. J.J. Swigris, A. Fischer, J. Gillis, R.T. Meehan, and K.K. Brown Pulmonary and thrombotic manifestations of systemic lupus erythematosus Chest 133 2008 271 280
53. A.A. Khorana The NCCN clinical practice guidelines on venous thromboembolic disease: strategies for improving VTE prophylaxis in hospitalized cancer patients Oncologist 12 2007 1361 1370
54. L.-A. Linkins, and T. Warkentin The approach to heparin-induced thrombocytopenia Semin Respir Crit Care Med 2008 066 074